Ropes & Gray represented ImmunoGen, Inc., a leader in antibody-drug conjugates (ADC) for the treatment of cancer, in a term loan financing for up to $175 million with entities managed by Pharmakon Advisors. The financing was announced on April 6. Under the terms of the agreement, the loan facility will be available to ImmunoGen in two tranches. The […]
The post Ropes & Gray Advises ImmunoGen in Term Loan Financing Up to $175 Million appeared first on Legal Desire Media and Insights.